Related Experiment Video
Updated: Nov 18, 2025

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
Published on: January 28, 2014
GDF-15 as a Biomarker in Cardiovascular Disease
Bruna Miers May1, Mauricio Pimentel2, Leandro Ioschpe Zimerman2
1Universidade Federal do Rio Grande do Sul - Programa de Pós-Graduação em Ciências da Saúde: Cardiologia e Ciências Cardiovasculares , Porto Alegre , RS - Brasil.
Growth differentiation factor-15 (GDF-15) shows promise as a diagnostic and prognostic biomarker in cardiovascular disease. This review summarizes evidence on GDF-15
Area of Science:
- Cardiology
- Biomarker Discovery
- Molecular Biology
Background:
- Cardiovascular disease diagnosis and prognosis rely on identifying reliable biomarkers.
- Growth differentiation factor-15 (GDF-15), a cytokine in the transforming growth factor- (TGF-) superfamily, is upregulated during stress and inflammation.
- GDF-15 has been linked to myocardial injury and cardiac overload in preclinical models.
Purpose of the Study:
- To review and synthesize current research on the diagnostic and prognostic utility of GDF-15.
- To evaluate GDF-15's role across various cardiovascular conditions.
- To highlight GDF-15 as a potential predictive biomarker for cardiovascular events and mortality.
Main Methods:
- Systematic literature review of studies investigating GDF-15 in cardiovascular disease.
- Analysis of data from population studies and clinical trials.
- Evaluation of GDF-15's correlation with cardiovascular events, mortality, and specific cardiac conditions.
Main Results:
- GDF-15 is consistently upregulated in conditions associated with cardiovascular disease.
- Population studies show a positive correlation between GDF-15 levels and increased risk of cardiovascular events.
- GDF-15 is an independent predictor of mortality in patients with coronary artery disease and heart failure.
Conclusions:
- GDF-15 demonstrates significant potential as a diagnostic and prognostic biomarker in cardiology.
- Its independent predictive value for mortality underscores its clinical relevance.
- Further research is warranted to fully elucidate GDF-15's role in cardiovascular risk stratification and management.
More Related Videos
10:02Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography FDG-PET/CT
Published on: May 2, 2012
08:42Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...